跳至主要内容
临床试验/NCT02389803
NCT02389803已完成不适用

Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys

Rabin Medical Center3 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2015年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
3
主要终点
Weight SDS (standard deviation score)

研究概览

简要总结

Study design:

Double blind, randomized, placebo controlled study. Participants will be randomly assigned either to the intervention group or the placebo control group. Randomization for the two study groups will be made in a ratio of 1:1.

The primary objective of the study is to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean boys adolescents on weight Standard Deviation Score (SDS) and height SDS The Secondary Objectives of the study are to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean boys adolescents on BMI SDS, growth velocity, time to puberty, quality of life and self-esteem The study will continue for 6 months of intervention versus active placebo, with additional optional 6 months (an extension period), in which participants at both groups, the intervention and the placebo, will be offered to continue their participation in the study with the study supplement. All analyses of the effect's on primary and secondary outcome measurements will take into account the consumption rate of the study formula/placebo

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
10 Years 至 15 Years(Child)
性别
Male
接受健康志愿者
否

入选标准

  • •Boys aged ≥10years old
  • •Prepubertal - Tanner stage 1 (gonadarche) (testicular volume<4)
  • •Height and weight ≤ 10th percentile for age and gender.
  • •Height-SDS ≥ -2.5 SDS
  • •BMI-SDS>-3 SDS
  • •Low proportion between weight and height
  • •Signing inform consent forms

排除标准

  • •Diagnosis of Growth Hormone (GH) Deficiency or treatment with GH
  • •Any known chronic disease or dysmorphic syndrome including: bone diseases, organic brain diseases, neurological disease, past or current malignancy, chronic cardiac, renal or pulmonary problems
  • •Any known gastrointestinal disease including malabsorption
  • •Any known organic reason for growth retardation

研究组 & 干预措施

Nutritional supplementation standardized formula

Experimental

Powder added to water, containing about 25% of recommended Daily Recommended Intake (DRI) for Calories, high protein (25% of calories) and multi vitamin and mineral (25%-100% of DRI for recommended daily allowance (RDA) or adequate intake )

干预措施: Nutritional supplementation standardized formula (Dietary Supplement)

Placebo comparator

Placebo Comparator

Low caloric formula (Powder added to water), without added vitamins and mineral

干预措施: Placebo comparator (Dietary Supplement)

结局指标

主要结局

Weight SDS (standard deviation score)

时间窗: At 6 months

Height SDS (standard deviation score)

时间窗: At 6 months

Height SDS (standard deviation score)

时间窗: At 12 months

Weight SDS (standard deviation score)

时间窗: At 12 months

次要结局

  • BMI SDS (standard deviation score)(At 6 months)
  • Growth velocity(At 6 months)
  • Self-esteem (Self-Esteem Questionnaire)(At 6 months)
  • Quality of life(At 6 months)
  • BMI SDS (standard deviation score)(At 12 months)
  • Growth velocity(At 12 months)
  • Quality of life(At 12 months)
  • Self-esteem (Self-Esteem Questionnaire)(At 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验